Published in Eur J Immunol on August 01, 1999
Distinct requirements for the naturally occurring splice forms Stat4alpha and Stat4beta in IL-12 responses. EMBO J (2003) 1.39
Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice. Infect Immun (2007) 1.09
STAT4 is a critical mediator of early innate immune responses against pulmonary Klebsiella infection. J Immunol (2004) 1.06
Pivotal role of signal transducer and activator of transcription (Stat)4 and Stat6 in the innate immune response during sepsis. J Exp Med (2001) 1.04
Does T Helper Differentiation Correlate with Resistance or Susceptibility to Infection with L. major? Some Insights From the Murine Model. Front Immunol (2012) 0.98
Association of variants in innate immune genes with asthma and eczema. Pediatr Allergy Immunol (2011) 0.93
A STAT4-dependent Th1 response is required for resistance to the helminth parasite Taenia crassiceps. Infect Immun (2004) 0.88
Adjuvant effect of anti-4-1BB mAb administration in adoptive T cell therapy of cancer. Int J Biol Sci (2007) 0.85
Infection-triggered regulatory mechanisms override the role of STAT 4 in control of the immune response to influenza virus antigens. J Virol (2003) 0.83
Role of co-stimulation in Leishmaniasis. Int J Biol Sci (2011) 0.83
STAT4 is critical for immunity but not for antileishmanial activity of antimonials in experimental visceral leishmaniasis. Eur J Immunol (2013) 0.78
Type 1 diabetes genetic susceptibility and dendritic cell function: potential targets for treatment. J Leukoc Biol (2016) 0.78
STAT4 rs7574865 polymorphism contributes to the risk of type 1 diabetes: a meta analysis. Int J Clin Exp Med (2015) 0.77
STAT4 regulates antiviral gamma interferon responses and recurrent disease during herpes simplex virus 2 infection. J Virol (2012) 0.77
Ox40L-Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major. Exp Parasitol (2014) 0.77
Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis. Cell Host Microbe (2017) 0.76
Th1 fate determination in CD4+ T cells: notice is served of the importance of IL-12! J Immunol (2008) 0.75
Modeling Immune Response to Leishmania Species Indicates Adenosine As an Important Inhibitor of Th-Cell Activation. Front Cell Infect Microbiol (2017) 0.75
Concepts of immunostimulation to increase antiparasitic drug action. Parasitol Res (2003) 0.75
Viral dynamics in human immunodeficiency virus type 1 infection. Nature (1995) 28.54
Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A (1966) 12.29
Alterations of macrophage functions by mediators from lymphocytes. J Exp Med (1971) 7.95
Genetic variation of Drosophila melanogaster natural populations. Trends Genet (1988) 4.62
Suppression of delayed hypersensitivity in vitro by inhibition of protein synthesis. J Exp Med (1965) 4.62
The enhancement of macrophage bacteriostasis by products of activated lymphocytes. J Exp Med (1973) 4.51
A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni. J Immunol (1979) 4.17
Characterization of a lymphocyte factor which alters macrophage functions. J Exp Med (1973) 3.98
Leukotactic factor produced by sensitized lymphocytes. Science (1969) 3.95
An in vitro assay for cellular hypersensitivity in man. J Immunol (1970) 3.73
Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators. Prog Allergy (1972) 3.47
Macrophage migration. Fed Proc (1990) 3.39
Studies on mediator production by highly purified human T and B lymphocytes. J Exp Med (1974) 3.38
Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med (1999) 3.23
The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor. Cell Immunol (1970) 3.17
SAP controls T cell responses to virus and terminal differentiation of TH2 cells. Nat Immunol (2001) 2.95
rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J Infect Dis (1996) 2.93
Studies on migration inhibitory factor (MIF): recovery of MIF activity after purification by gel filtration and disc electrophoresis. Cell Immunol (1970) 2.86
Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. J Clin Invest (1978) 2.84
Passive transfer by cells of type II collagen-induced arthritis in rats. J Clin Invest (1978) 2.81
Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein. J Immunol (1979) 2.81
Cellular sensitivity to collagen in rheumatoid arthritis. N Engl J Med (1978) 2.50
Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. J Immunol (1986) 2.31
Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc Natl Acad Sci U S A (1989) 2.24
Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol (2001) 2.20
The compartmentalization of antigen-reactive lymphocytes in desensitized guinea pigs. J Exp Med (1971) 2.18
Metabolic and functonal studies on activated mouse macrophages. J Exp Med (1973) 2.17
Leishmania species: models of intracellular parasitism. J Cell Sci (1999) 2.13
Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: damage by purieid eosinophils. J Exp Med (1977) 2.06
Macrophage activation by lymphocyte mediators. Fed Proc (1975) 1.99
Studies on control of visceral leishmaniasis: impact of dog control on canine and human visceral leishmaniasis in Jacobina, Bahia, Brazil. Am J Trop Med Hyg (1998) 1.99
Host-plant specialization in the Drosophila melanogaster species complex: a physiological, behavioral, and genetical analysis. Proc Natl Acad Sci U S A (1991) 1.98
Similarities and differences in latitudinal adaptation of two Drosophila sibling species. Nature (1975) 1.96
Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae. Proc Natl Acad Sci U S A (1986) 1.93
Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial. Clin Infect Dis (2005) 1.91
Evolution in a cosmopolitan species: genetic latitudinal clines in Drosophila melanogaster wild populations. Experientia (1975) 1.91
Immunochemical studies on the specificity of cellular hypersensitivity. The in vitro inhibition of peritoneal exudate cell migration by cehmically defined antigens. J Exp Med (1968) 1.90
Monoclonal antibodies that distinguish between New World species of Leishmania. Nature (1981) 1.89
Characterization of migration inhibitory factor (MIF) from guinea pig lymphocytes stimulated with concanavalin A. J Immunol (1972) 1.82
Mediators produced by sensitized lymphocytes. Fed Proc (1972) 1.79
Mitochondrial DNA variability in Drosophila simulans: quasi absence of polymorphism within each of the three cytoplasmic races. Heredity (Edinb) (1988) 1.76
Sandfly maxadilan exacerbates infection with Leishmania major and vaccinating against it protects against L. major infection. J Immunol (2001) 1.74
Activation of human blood monocytes by products of sensitized lymphocytes. J Clin Invest (1974) 1.73
Maternal-fetal relation. Absence of an immunologic blocking factor from the serum of women with chronic abortions. N Engl J Med (1976) 1.69
Schistosoma mansoni: rapid isolation and purification of schistosomula of different developmental stages by centrifugation on discontinuous density gradients of Percoll. Exp Parasitol (1982) 1.66
Identification and distribution of New World Leishmania species characterized by serodeme analysis using monoclonal antibodies. Am J Trop Med Hyg (1987) 1.65
Prevention of MIF activity by agents known to increase cellular cyclic AMP. J Immunol (1973) 1.64
Transfer of cellular hypersensitivity in chronic mucocutaneous candidiasis monitored in vivo and in vitro. Cell Immunol (1970) 1.64
In vivo and in vitro characterization of murine T-cell clones reactive to Mycobacterium tuberculosis. Infect Immun (1987) 1.63
Template/primer requirements and single nucleotide incorporation by hepatitis C virus nonstructural protein 5B polymerase. J Virol (2000) 1.63
Characterization of human migration inhibitory factor (MIF) from antigen-stimulated lymphocytes. Cell Immunol (1972) 1.63
Cutting edge: selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection. J Immunol (2000) 1.63
Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett (1997) 1.58
Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages. Proc Natl Acad Sci U S A (1981) 1.54
Lymphocyte mediators and cellular hypersensitivity. N Engl J Med (1973) 1.53
Poliovirus RNA-dependent RNA polymerase (3D(pol)). Divalent cation modulation of primer, template, and nucleotide selection. J Biol Chem (1999) 1.53
Schistosoma mansoni. Anti-egg monoclonal antibodies protect against cercarial challenge in vivo. J Exp Med (1984) 1.51
Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia. N Engl J Med (1980) 1.50
Genetics of morphological differences and hybrid sterility between Drosophila sechellia and its relatives. Genet Res (1991) 1.49
Molluscum contagiosum after eyebrow shaping: a beauty salon hazard. Clin Exp Dermatol (2009) 1.48
Induction of Th2 responses and IgE is largely due to carbohydrates functioning as adjuvants on Schistosoma mansoni egg antigens. J Immunol (1999) 1.47
Enzymatic and quantitative variation in European and African populations of Drosophila simulans. Heredity (Edinb) (1985) 1.47
Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells. J Immunol (1976) 1.47
The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervous-tissue antigens. N Engl J Med (1971) 1.47
Species-specific 18S rRNA gene amplification for the detection of P. falciparum and P. vivax malaria parasites. Mol Cell Probes (1995) 1.46
Lacto-N-fucopentaose III found on Schistosoma mansoni egg antigens functions as adjuvant for proteins by inducing Th2-type response. J Immunol (2001) 1.45
Tonsillar size is an important indicator of recurrent acute tonsillitis. Clin Otolaryngol Allied Sci (2004) 1.45
Intranasal application of purified protein derivative suppresses the initiation but not the exacerbation of allergic rhinitis in mice. Clin Exp Allergy (2002) 1.45
Autoimmunity to collagen in adjuvant arthritis of rats. J Clin Invest (1980) 1.44
Low allozyme and mtDNA variability in the island endemic species Drosophila sechellia (D. melanogaster complex). Experientia (1990) 1.42
In vitro studies of the suppression of delayed hypersensitivity by the induction of partial tolerance. J Exp Med (1970) 1.41
Universal scaling laws of diffusion in a binary fluid mixture. Phys Rev Lett (2001) 1.41
Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages. J Exp Med (1987) 1.41
Stress-induced enhancement of skin immune function: A role for gamma interferon. Proc Natl Acad Sci U S A (2000) 1.39
IgE antibody and resistance to infection. I. Selective suppression of the IgE antibody response in rats diminishes the resistance and the eosinophil response to Trichinella spiralis infection. J Exp Med (1981) 1.36
Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection. Infect Immun (2001) 1.36
In vitro lymphocyte response of patients with immunologic deficiency diseases. N Engl J Med (1970) 1.34
Interactions between human eosinophils and schistosomula of Schistosoma mansoni. II. The mechanism of irreversible eosinophil adherence. J Exp Med (1979) 1.34
Retracted Human recombinant migration inhibitory factor activates human macrophages to kill Leishmania donovani. J Immunol (1991) 1.33
In vitro evidence for cellular hypersensitivity to glomerular-basement-membrane antigens in human glomerulonephritis. N Engl J Med (1970) 1.33
Widespread occurrence of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) gene haplotype SVMNT in P. falciparum malaria in India. Am J Trop Med Hyg (2004) 1.33
Retracted Recombinant migration inhibitory factor induces nitric oxide synthase in murine macrophages. J Immunol (1993) 1.31
Further studies on migration inhibitory factor (MIF): evidence for its glycoprotein nature. J Immunol (1971) 1.30
Bayesian analysis and model selection for interval-censored survival data. Biometrics (1999) 1.28
Leishmaniasis: clinical syndromes and treatment. QJM (2013) 1.27
Macrophages activated as suspension cultures with lymphocyte mediators devoid of antigen become cytotoxic for tumor cells. J Immunol (1975) 1.27
Monoclonal antibodies that distinguish subspecies of Leishmania braziliensis. J Immunol (1982) 1.27
Biosynthetic defect in monocytes from human beings with genetic deficiency of the second component of complement. N Engl J Med (1975) 1.27
A microsatellite-based multilocus phylogeny of the Drosophila melanogaster species complex. Curr Biol (1998) 1.26
Enhancement of human blood eosinophil cytotoxicity by semi-purified eosinophil colony-stimulating factor(s). J Exp Med (1982) 1.25
Comparative analysis of morphological traits among Drosophila melanogaster and D. simulans: genetic variability, clines and phenotypic plasticity. Genetica (2004) 1.23
In vitro demonstration of cellular sensitivity in allergic encephalomyelitis. J Exp Med (1965) 1.22
Competence of the human host as a reservoir for Leishmania chagasi. J Infect Dis (2000) 1.21
Short-range genetic structure of Drosophila melanogaster populations in an Afrotropical urban area and its significance. Proc Natl Acad Sci U S A (1989) 1.21
Leukocyte inhibitory factor (LIF): production by purified human T and B lymphocytes. J Immunol (1975) 1.19
Biological role of alcohol dehydrogenase in the tolerance of Drosophila melanogaster to aliphatic alochols: utilization of an ADH-null mutant. Biochem Genet (1976) 1.19